KonzernSprachenDeutschEnglischSprache nicht verfügbarSprache nicht verfügbar
Seitenkopf
Search

RHÖN-KLINIKUM AG

Notification according to section 26 para. 1 WpHG

Morgan Stanley & Co International Plc, London, UK, Morgan Stanley UK Group, London, UK, Morgan Stanley Group (Europe), London, UK, Morgan Stanley International Limited, London, UK, Morgan Stanley International Holdings Inc, Delaware, USA, and Morgan Stanley, Delaware, USA notified us pursuant to section 25 WpHG of the following:

1) On 11 June 2012, Morgan Stanley & Co International Plc exceeded the threshold of 5% of the voting rights of RHÖN-KLINIKUM AG, Salzburger Leite 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, Morgan Stanley & Co International Plc held 5.18% of the voting rights in RHÖN-KLINIKUM AG (equals 7,161,101 voting rights). From these voting rights a proportion of 3.94% (equals 5,449,714 voting rights) is based on voting rights pursuant to sections 21, 22 WpHG and a proportion of 1.24% (equals 1,711,387 voting rights) is based on (financial / other) instruments pursuant to section 25 WpHG. From the voting rights based on instruments pursuant to section 25 WpHG a proportion of 0.06% (equals 85,500 voting rights) is held indirectly (chain of controlled undertakings: Morgan Stanley Turnberry Limited, Morgan Stanley Equity Derivative Services (Luxembourg) S.a.r.l.). The instruments pursuant to section 25 WpHG are retransfer claims based on various contracts that can be exercised at the lender’s discretion.

2) On 11 June 2012, Morgan Stanley UK Group exceeded the threshold of 5% of the voting rights of RHÖN-KLINIKUM AG, Salzburger Leite 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, Morgan Stanley UK Group held 5.18% of the voting rights in RHÖN-KLINIKUM AG (equals 7,161,101 voting rights). From these voting rights a proportion of 3.94% (equals 5,449,714 voting rights) is based on voting rights pursuant to sections 21, 22 WpHG and a proportion of 1.24% (equals 1,711,387 voting rights) is based on (financial / other) instruments pursuant to section 25 WpHG. From the voting rights based on instruments pursuant to section 25 WpHG a proportion of 1.24% (equals 1,711,387 voting rights) is held indirectly (chain of controlled undertakings: Morgan Stanley & Co International Plc; Morgan Stanley Turnberry Limited, Morgan Stanley Equity Derivative Services (Luxembourg) S.a.r.l.). The instruments pursuant to section 25 WpHG are retransfer claims based on various contracts that can be exercised at the lender’s discretion.

3) On 11 June 2012, Morgan Stanley Group (Europe) exceeded the threshold of 5% of the voting rights of RHÖN-KLINIKUM AG, Salzburger Leite 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, Morgan Stanley Group (Europe) held 5.18% of the voting rights in RHÖN-KLINIKUM AG (equals 7,161,101 voting rights). From these voting rights a proportion of 3.94% (equals 5,449,714 voting rights) is based on voting rights pursuant to sections 21, 22 WpHG and a proportion of 1.24% (equals 1,711,387 voting rights) is based on (financial / other) instruments pursuant to section 25 WpHG. From the voting rights based on instruments pursuant to section 25 WpHG a proportion of 1.24% (equals 1,711,387 voting rights) is held indirectly (chain of controlled undertakings: Morgan Stanley UK Group; Morgan Stanley & Co International Plc; Morgan Stanley Turnberry Limited, Morgan Stanley Equity Derivative Services (Luxembourg) S.a.r.l.). The instruments pursuant to section 25 WpHG are retransfer claims based on various contracts that can be exercised at the lender’s discretion.

4) On 11 June 2012, Morgan Stanley International Limited exceeded the threshold of 5% of the voting rights of RHÖN-KLINIKUM AG, Salzburger Leite 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, Morgan Stanley International Limited held 5.18% of the voting rights in RHÖN-KLINIKUM AG (equals 7,161,101 voting rights). From these voting rights a proportion of 3.94% (equals 5,449,714 voting rights) is based on voting rights pursuant to sections 21, 22 WpHG and a proportion of 1.24% (equals 1,711,387 voting rights) is based on (financial / other) instruments pursuant to section 25 WpHG. From the voting rights based on instruments pursuant to section 25 WpHG a proportion of 1.24% (equals 1,711,387 voting rights) is held indirectly (chain of controlled undertakings: Morgan Stanley Group (Europe); Morgan Stanley UK Group; Morgan Stanley & Co International Plc; Morgan Stanley Turnberry Limited, Morgan Stanley Equity Derivative Services (Luxembourg) S.a.r.l.). The instruments pursuant to section 25 WpHG are retransfer claims based on various contracts that can be exercised at the lender’s discretion.

5) On 11 June 2012, Morgan Stanley International Holdings Inc exceeded the threshold of 5% of the voting rights of RHÖN-KLINIKUM AG, Salzburger Leite 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, Morgan Stanley International Holdings Inc held 5.25% of the voting rights in RHÖN-KLINIKUM AG (equals 7,260,722 voting rights). From these voting rights a proportion of 3.94% (equals 5,449,714 voting rights) is based on voting rights pursuant to sections 21, 22 WpHG and a proportion of 1.31% (equals 1,811,008 voting rights) is based on (financial / other) instruments pursuant to section 25 WpHG. From the voting rights based on instruments pursuant to section 25 WpHG a proportion of 1.31% (equals 1,811,008 voting rights) is held indirectly (chain of controlled undertakings: MS Equity Financing Services (Luxembourg) S.a.r.l; Morgan Stanley International Limited; Morgan Stanley Group (Europe); Morgan Stanley UK Group; Morgan Stanley & Co International Plc; Morgan Stanley Turnberry Limited, Morgan Stanley Equity Derivative Services (Luxembourg) S.a.r.l.). The instruments pursuant to section 25 WpHG are retransfer claims based on various contracts that can be exercised at the lender’s discretion.

6) On 11 June 2012, Morgan Stanley exceeded the threshold of 5% of the voting rights of RHÖN-KLINIKUM AG, Salzburger Leite 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, Morgan Stanley held 6.24% of the voting rights in RHÖN-KLINIKUM AG (equals 8,621,399 voting rights). From these voting rights a proportion of 4.03% (equals 5,568,769 voting rights) is based on voting rights pursuant to sections 21, 22 WpHG and a proportion of 2.21% (equals 3,052,630 voting rights) is based on (financial / other) instruments pursuant to section 25 WpHG. From the voting rights based on instruments pursuant to section 25 WpHG a proportion of 2.21% (equals 3,052,630 voting rights) is held indirectly (chain of controlled undertakings: MSDW Offshore Equity Services Inc; Fundlogic SAS; Morgan Stanley Capital Management LLC; Morgan Stanley Domestic Holdings Inc; Morgan Stanley & Co LLC; MS Equity Finance Services I (Cayman) Ltd; MS Equity Financing Services (Luxembourg) S.a.r.l; Morgan Stanley International Holdings Inc; Morgan Stanley International Limited; Morgan Stanley Group (Europe); Morgan Stanley UK Group; Morgan Stanley & Co International Plc; Morgan Stanley Turnberry Limited, Morgan Stanley Equity Derivative Services (Luxembourg) S.a.r.l.). The instruments pursuant to section 25 WpHG are retransfer claims based on various contracts that can be exercised at the lender’s discretion.


Bad Neustadt a.d. Saale, 18 June 2012

The Board of Management


Dr. Kai G. Klinger
Head of Investor Relations
RHÖN-KLINIKUM AG
Schlossplatz 1
97616 Bad Neustadt a. d. Saale
Phone: +49 9771 65 – 1318
Fax: +49 9771 99 - 1736
back